Figure 4
From: Human mesenchymal stem cells lose their functional properties after paclitaxel treatment
Paclitaxel treatment reduces the multi-lineage differentiation potential of MSCs. (a) BODIPY lipid staining of MSC1 and MSC2 samples after treatment with paclitaxel to assess induced adipogenic differentiation. (b) Alcian blue staining for induced chondrogenic differentiation of MSCs after exposure to paclitaxel. (c) OsteoImage™ staining for induced osteogenic differentiation of MSCs following paclitaxel treatment. Relative staining intensities were measured to quantify differentiation levels after differentiation. Data are mean +/− SD. *P < 0.05; **P < 0.01; ***P < 0.001.
